MB
Insider
Michael W Bonney
DirectorMichael W Bonney (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Alnylam Pharmaceuticals, Inc. (ALNY). The largest single filing was $5.1M of ALNY (11,250 sh × $450.00, as filed), executed Aug 18 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$8.0M
shares × price, as filed
Last traded
Aug 18 2025
Filed Aug 19 2025
Median ADV $470.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $8.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
ALNYRecent filings
ALNYSALE
Alnylam Pharmaceuticals, Inc.
View filing →
$5.1M11,250 sh × $450.00
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. View filing → $3.0M
10,704 sh across 12 lots
Exec May 15 2025
Filed May 19 2025 · 5:30 PM ET